Karyopharm Therapeutics
KPTI
KPTI
146 hedge funds and large institutions have $1.13B invested in Karyopharm Therapeutics in 2019 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5% more call options, than puts
Call options by funds: $16.5M | Put options by funds: $15.6M
5% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 39
0.04% less ownership
Funds ownership: 6.3% → 6.26% (-0.04%)
Holders
146
Holding in Top 10
5
Calls
$16.5M
Puts
$15.6M
Top Buyers
| 1 | +$40M | |
| 2 | +$18.9M | |
| 3 | +$15.7M | |
| 4 |
Two Sigma Investments
New York
|
+$14M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$6.76M |
Top Sellers
| 1 | -$84.3M | |
| 2 | -$24.4M | |
| 3 | -$19.1M | |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$18.1M |
| 5 |
ECP
Elk Creek Partners
Denver,
Colorado
|
-$15.5M |